作者对34名平均年龄26岁、平均病程17年的精神运动性癫痫病人,每天给予 Clonaz-epam2—12毫克,主要疗效的标志为第一个月发作减少50%以后持续进步。34人中,12人有这样的进步,12人中7人持续进步5个月或5个月以上,3人且停止发作。此外,作者发现此药对20名 Lennox 氏综合征 The author of 34 patients with a mean age of 26 years and an average duration of 17 years of psychomotor epilepsy was given Clonaz-epam 2-12 mg daily, the main efficacy of which was marked by a 50% reduction in episodes of the first month of continuous improvement. Among the 34 people, 12 people made such progress, 7 of them continued to progress for 5 months or more, 3 stopped their attacks. In addition, the authors found that the drug on 20 Lennox’s syndrome